Andrea Corcoran appointed as CFO and in-house counsel


Andrea Corcoran appointed as CFO and in-house counsel

We welcome Andrea Corcoran as the new Chief Financial Officer and In-House Counsel at MSM. Andrea has an extensive record of applying her expertise in the area of finance and law to the pharmaceutical industry. Most recently, she served as Senior Vice President of Finance at iBio, Inc. Prior to that, she worked as General Council at Tolerx, Inc for 4 years between 2007 and 2011. Likewise, before working at Tolerx she spent 8 years as General Counsel at Idenix Pharmaceuticals, taking the company from a pre-IND, venture-backed enterprise to a public company with a globally approved and marketed drug. Her prior work with early stage bioscience companies will bring invaluable knowledge to MSM.

About MSM Protein Technologies

MSM Protein Technologies is a closely held drug discovery company that specializes in discovering antibodies targeting complex cell surface receptors such as G Protein- Coupled Receptors (GPCRs). Using proprietary technologies originating at the Dana Farber Institute and developed within MSM, the company is able to overexpress the cell surface proteins in their native conformation, maximizing the possibility of discovering functional antibodies.

For more information: 781-321-3322